GT BIOPHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
GT BIOPHARMA, INC. (GTBP) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 597.55 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 597.55K shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 597.55K shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 597.55K shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 597.55K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed |
|---|---|---|
| 2026-06-30 | 597.55K shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 597.55K shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 597.55K shares 10-Q · filed 2026-08-14 | |
| 2025-09-30 | 597.55K shares 10-Q/A · filed 2026-03-06 | |
| 2025-06-30 | 124.60K shares 10-Q/A · filed 2026-03-06 | |
| 2025-03-31 | 124.60K shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 124.60K shares 10-Q/A · filed 2026-03-06 | |
| 2024-09-30 | 101.26K shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 126.27K shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 126.27K shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 126.27K shares 10-K · filed 2026-03-02 | |
| 2023-09-30 | 3.74M shares 10-Q · filed 2023-11-01 | |
| 2023-06-30 | 3.74M shares 10-Q · filed 2023-08-07 | |
| 2023-03-31 | 3.47M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 54.35K shares 10-K · filed 2025-02-21 | 1.63M shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 1.84M shares 10-Q · filed 2022-10-31 | |
| 2022-06-30 | 302.50K shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 302.50K shares 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 10.08K shares 10-K · filed 2024-03-26 | 302.50K shares 10-K · filed 2022-03-28 |
| 2020-12-31 | 0.00 shares 10-K · filed 2021-04-16 | |
| 2020-09-30 | 40.00 shares 10-Q · filed 2020-11-13 | |
| 2020-06-30 | 40.00 shares 10-Q/A · filed 2020-08-18 | |
| 2020-03-31 | 40.00 shares 10-Q · filed 2020-05-15 | |
| 2019-12-31 | 3.00 shares 10-K · filed 2021-04-16 | 40.00 shares 10-K · filed 2020-03-27 |
| 2018-12-31 | 66.00 shares 10-K · filed 2021-04-16 | 1.11K shares 10-K · filed 2019-03-29 |
| 2017-12-31 | 1.25K shares 10-K · filed 2020-03-27 | |
| 2016-12-31 | 1.25K shares 10-K · filed 2019-03-29 | |
| 2015-12-31 | 1.25K shares 10-K · filed 2018-03-01 | |
| 2012-12-31 | 40.09M shares 10-K · filed 2014-11-18 | |
| 2012-09-30 | 38.78M shares 10-Q · filed 2012-11-21 | |
| 2012-06-30 | 38.84M shares 10-Q/A · filed 2012-09-13 | |
| 2011-12-31 | 16.08M shares 10-K · filed 2014-11-18 | |
| 2010-12-31 | 13.93M shares 10-K · filed 2014-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |